The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
One last day to get on board before the company blasts into orbit, all indicators points to there being great results, time will tell, 4D isn’t a one trick pony and if the previous poster was correct about knowing the news is good then there is no risk. I am going to top up today to double my holding on any weakness
Best to let the results do the talking. No amount of ramping will change the outcome of the results. Best to buy and hold.
Each to their own.
Buy or sell, Good luck and DYOR.
I know I will buy more if it drops today.
A few weeks ago:
sp hit 148p, then dropped to 105p, and then went back up to over 148p to 160p.
Hope news this week sends this much much higher!
MM's in full control today
Yep with the car crash at val the short term traders can't hang around.
As we said before all dips get bought into.
Sit back.
Loads of panic sells, they will regret tomorrow
When it’s up 40% ;)
Question to CEO?
With 3 and half months until the end of the year, do you have any milestones that you will be announcing that will generate further highs in the stock price.
Duncan, yes ' we have just finished a trial in IBS, then explains the size of the market and that the current drugs don't really work because of the side effects and he is hopeful that they have.
Results out later this month/early next month.
Wow, he will know the results generally and this confirms that he sees this announcement as a milestone that will generate further highs in the stock price.
Question to CEO... wheres my 5quid a share you fekicn +_)@:>?{+_+))()
:-0
In general and across sectors it is better if there is a fall in the price leading up to the announcement of major news ... always within reason and as long as movements happen above the long term average. If we go much below 145p today and for some time then ... it's more difficult to attribute the fall only to stop losses and look for the persistent seller / global crash/ other reasons.
And a a couple more points:
- this share has risen from high 30s, 40s and 50s to almost 180p yesterday. There is bound to be turbulence, corrections, profit taking and MM interventions (lacking a better word).
- 4D is mainly a long term investment not least because of the sector. It became a short term one AS WELL because of the fire sales by the funds in late spring/early summer. That was precisely when the company was close to start reaping the harvest of many years of efforts. And... it seems to be only the exciting start.
And by the way, it's not necessarily the last day before the results.
'Could' not 'will' liquid1.
Might not be the last day tomorrow CEO said end of Sept, beginning of October so don’t panic if RNS doesn’t drop tomorrow.
Huge Q4 for this company JMO,DYOR.
I’m in balls deep GLA.
Yep - feels like SP dropping on inpatient holders cashing in. Short sighted
Good to see the weak leaving.
Fall seems a bit more persistent than one might expect. Here is a possibility or speculation:
the IBS news are widely expected to be anything between moderately good to excellent. However the company will need funding at some point and why leave it to the last minute? They may be looking at announcing the results and a placement to follow suit. If that's indeed the case negotiations must be on-going and the price could be anywhere in the 125-150p band: the better the results the higher the price of the placement. Even at 125p it would be a vote of confidence in the company given where the earlier placements took place.
This is total speculation as, otherwise, I don't see why there is such prolonged effect on 4D price. Also, the price isn't high enough for parties to start shorting the price.
What we don't know is that these results may trigger a stage payment from Merck...;)
Terrier.. they probably working through that with Merck now
Could well be something going on in the background. I'm sure the company already know the results. At least we have seen the bed-wetters leave the party today and yesterday. Clears the pipes out.
I suspect Merck may also have some other ideas if they can have the whole company for relatively modest outlay why trigger milestone payment?
H202
What valuation would you put on the company?
Terrier
It is very difficult to value the company without inside information on success rates for the pipeline.
As a random value upwards of £1 billion.
Very early for Merck or anyone to buy the company. 4D pharma is only now beginning to show its teeth and ... value.
It would make more sense for Merck (or others) to buy 4D after for, say, a few billion dollars in 12-18 months (assuming positive outcome of part B trial phase I/II in oncology, IBS and progress on the neurodegeration front), rather than buy it now for say USD 1 billion.
Most importantly, I believe 4D management would wish to unlock a lot more of the potential before they even talk about takeover.
That's a general sector trend ... not just particular to 4D. Most licensing deals (or even takeovers) would concern companies with drugs that have just completed successful phase I/II or phase II trials.
After all, current arrangement suits everyone: Merck is close enough to be able to move quickly and do further deal(s) with 4D as positive results continue to flow out of 4D's R&D powerhouse. And even though, the top secret vaccine collaboration project is a tight ship ... we are likely to see some news emerge.
Hold for GOLD. At some point the SP is going to fly !! Hold tight folks...;o))
Staring to rise again